SEC Form 4 · accession 0001016353-15-000005
KUBOTA PHARMACEUTICAL HOLDINGS CO LTD · M??????
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Edward H Danse
Officer — Chief Business Officer
Period of report
May 1, 2015
Accepted (ET)
May 5, 2015 · 8:54 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001400482
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1,F2 | May 1, 2015 | A | 118,369 | $0.00 | A | 118,369 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The issuer's common stock trades on the Tokyo Stock Exchange under the symbol referenced in the issuer's registration statement on Form S-1 (File No. 333-192000).
- F2Mr. Danse was granted 118,369 shares of restricted stock which will be subject to repurchase by the issuer over a four (4) year period if the reporting person's employment is terminated, with 75% of the restricted stock subject to repurchase through 5/1/2016, and the remaining thereafter on a decreasing percentage on a monthly pro rata basis over the following three (3) years, terminating on 5/1/2019.